The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT07272343
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT07272343
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07272343. Randomized; no masking; primary purpose treatment. Start 2023-02-10 (actual); primary completion 2026-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes
- Condition
- Type 2 Diabetes Mellitus (T2DM)
- Condition
- Semaglutide
- Condition
- Caloric Restriction
- Intervention (Drug)
- semaglutide
- Intervention (Behavioral)
- caloric restriction
- Lead sponsor
- Second Affiliated Hospital of Nanchang University
Record details
- Record id
cardio:ct-nct07272343- Content hash
05a3879b40fb116adaf7404e0a060ce50b585cba7969fa60c423002d1921f9dd